Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Pay Now 2500 Secure Payments Powered By Whats Included in Your Blood Analysis
North Carolina Department of Health and Human Services
Key evidence points: GLP-1 medications do not directly target or break down muscle tissue Lean mass loss occurs as a consequence of the calorie deficit and weight reduction The proportion of lean mass lost is comparable to other weight loss methods Greater absolute lean mass loss reflects the greater total weight loss achieved Regulatory bodies including NICE and the MHRA have not identified muscle loss as a specific adverse effect requiring special warnings in the Summary of Product Characteristics (SmPCs), though healthcare professionals are advised to monitor nutritional status and encourage appropriate dietary protein intake and physical activity in patients using these medications for weight management
GEP44 agonism at Y1-R and Y2-R was validated in assays that monitored their ability to counteract adenosine-stimulated cAMP production in HEK293 C24 cells that were transiently transfected with Y1-R or Y2-R 16,46
